Results · Apr-Jun 2026 · filed 11 Aug 2026
PI Industries Q1 FY27 results
Sales fell 10% to ₹1,702 crore from ₹1,901 crore in Apr-Jun 2025.
Operating profit fell 29% to ₹367 crore, an operating margin of 21.6% (down 5.7 points from a year ago).
Net profit fell 39% to ₹244 crore from ₹400 crore in Apr-Jun 2025.
Against Jan-Mar 2026: sales +9%, net profit +22%.
Apr-Jun 2026 vs a year ago
| ₹ crore | Apr-Jun 2026 | Apr-Jun 2025 | Change |
|---|---|---|---|
| Sales | 1,702 | 1,901 | −10% |
| Operating profit (EBITDA) | 367.4 | 519.1 | −29% |
| Operating margin | 21.6% | 27.3% | −5.7 pts |
| Net profit | 244.2 | 400.0 | −39% |
Consolidated figures. Margins & ratios change in percentage points (pts).
The earnings call
Apr–Jun 2026 revenue was ₹1,702 crore with 57% gross margin & 22% EBITDA margin. Domestic volumes grew 12% despite delayed sowing; biologicals surged 50%. Management expects FY27 to be better than FY26 with recovery in exports & new product launches.
The last 7 quarters
Filings that week
- 14 Aug 2026Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
- 14 Aug 2026Shareholder Meeting / Postal Ballot-Outcome of AGM
- 13 Aug 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
- 13 Aug 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
- 13 Aug 2026Announcement under Regulation 30 (LODR)-Newspaper Publication
- 12 Aug 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
- 12 Aug 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
- 11 Aug 2026Announcement under Regulation 30 (LODR)-Investor Presentation
From the company's results filed on BSE (Consolidated). Business numbers only. Education & analysis, not investment advice or a recommendation.